Payment Schedules; Reports Clause Samples
The 'Payment Schedules; Reports' clause defines the timing and structure of payments as well as the reporting requirements between parties. It typically outlines when payments are due, the intervals or milestones that trigger payments, and the format or content of financial or progress reports that must be submitted. This clause ensures both parties have a clear understanding of financial obligations and reporting expectations, reducing the risk of disputes over payment timing or documentation.
Payment Schedules; Reports. The payments due pursuant to Sections 3.5.2, 6.1, 6.2 and 10.3.5 are due and payable on the dates described therein. Royalty payments due pursuant to Section 6.3 are due and payable within thirty-five (35) days of the end of each calendar quarter during the Term during which there were Net Sales of Collaboration Products in the ROW Territory. Shire will accompany each payment of royalties under this Agreement with a report setting forth, on a country-by-country basis, the amount of gross sales of each Collaboration Product in such country, a calculation of Net Sales, the currency conversion rate used and the United States Dollar-equivalent of such Net Sales, and a calculation of the amount of royalty payment due on such Net Sales. Such report will be considered Confidential Information of Shire subject to the obligations of Article 9 of this Agreement. The Parties acknowledge that any expenses or costs reported or shared in any way under this Agreement may be based upon estimates, which estimates will be GAAP-compliant; provided that when the actual results become known relative to any estimated amount, any difference between the actual results and the estimate is reported and the next payment due hereunder related to such estimated item is appropriately adjusted for such difference. The Parties acknowledge and agree that any reports and payments relating to any cost, expense, or other financial amount shared pursuant to this Agreement for the fourth quarter of any calendar year shall reflect year-end reconciliations and adjustments, if any, applicable to the previous three quarters’ reported results.
Payment Schedules; Reports. The payment due pursuant to Section 8.1 is due and payable on the date described therein. Royalty payments due pursuant to Section 8.3 are due and payable quarterly [***] days after the end of each JBI Accounting Quarter. JBI will accompany each payment of royalties under this Agreement with a report setting forth, on a Pharmacological Profile-by-Pharmacological Profile, Licensed Product-by-Licensed Product, Indication-by-Indication and country-by-country basis, Net Sales, any currency conversion made in accordance with Section 9.4, and a calculation of the amount of royalty payment due on such Net Sales. Without limiting the foregoing, JBI shall require all of its applicable Affiliates and Sublicensees to account for their respective Net Sales and to provide such reports with respect thereto as if such sales were made by JBI.
Payment Schedules; Reports. The payments due pursuant to Sections 3.7.2, 7.1, 7.2, 7.3, 7.4 and 11.3.5 are due and payable on the dates described therein. The Parties acknowledge that any expenses or costs reported or shared in any way under this Agreement may be based upon estimates, which estimates will be GAAP-compliant; provided that when the actual results become known relative to any estimated amount, any difference between the actual results and the estimate is reported and the next payment due hereunder related to such estimated item is appropriately adjusted for such difference. The Parties acknowledge and agree that any reports and payments relating to any cost, expense, or other financial amount shared pursuant to this Agreement for the fourth quarter of any calendar year shall reflect year-end reconciliations and adjustments, if any, applicable to the previous three quarters’ reported results.
Payment Schedules; Reports. The payments due pursuant to Sections 7.1 and 7.2 are due and payable on the dates described therein. The Parties acknowledge that any expenses or costs reported under this Agreement may be based upon estimates, which estimates shall be made in compliance with GAAP consistently applied by such Party in accordance with past practice; provided that when the actual results become known relative to any estimated amount, any difference between the actual results and the estimate is reported and the next payment due hereunder related to such estimated item is appropriately adjusted for such difference. The Parties acknowledge and agree that any reports and payments relating to any cost, expense, or other financial amount shared pursuant to this Agreement for the [*] of any [*] shall reflect [*] reconciliations and adjustments, if any, applicable to the previous [*] reported results.
Payment Schedules; Reports. Performance payments due pursuant to Section 4.3 are due and payable within forty-five (45) days after the end of each calendar quarter in which there were Net Sales. Mist or its designated Affiliate, as applicable, will accompany each payment under this Agreement with a report setting forth the amount of gross sales of each Product, a calculation of Net Sales and a calculation of the amount of payment due on such Net Sales (including any adjustment for Generic Competition).
Payment Schedules; Reports. Royalty payments due pursuant to Section 8.3 are due and payable within [***] of the end of each calendar quarter during the Royalty Term during which there were Net Sales of the applicable product in North America. Micromet will accompany each payment of royalties under this Agreement with a report containing a detailed account of Net Sales of each product for which royalties are due during the preceding calendar quarter. *** Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.
Payment Schedules; Reports. During the Phase I Exclusive Period, HDL shall be invoiced with each shipment of Corgenix Manufactured Reagents with payment due Net 30 days. Beginning with the Phase II Exclusive Period, HDL shall provide to Corgenix an accounting of the aggregate Reported Tests on a calendar monthly basis within thirty (30) days after the end of such month. Except to the extent the payment hereunder is under review pursuant to Section 5.5, the payments due pursuant to this ARTICLE 5 are due and payable within thirty (30) days after the end of each calendar month.
Payment Schedules; Reports. Payments due pursuant to Sections 5.4.3, 6.1.3, 7.11.2, 13.2, and 13.3 are due and payable within [***] of the end of each calendar quarter during the Term during which there were Net Sales in the Territory or Net Profits in Europe. Each payment will be accompanied with a report containing a detailed account of the calculation of such Net Sales and Net Profits.
Payment Schedules; Reports. The milestone payments due pursuant to Section 7.2 are due and payable within [***] days after the achievement of the applicable milestone *** Certain information in this document has been omitted and filed separately with the Commission. Confidential treatment has been requested with respect to the omitted portions. event set forth in Exhibit E. Royalty payments due pursuant to Section 7.3 are due and payable within [***] days of the end of each calendar quarter during the Term during which there were Net Sales of any Product in the Territory. Nycomed shall accompany each payment of royalties under this Agreement with a report containing a detailed and itemized calculation of Net Sales of all Products in the Territory during the preceding calendar quarter, including a description of the dates and territories in which any Product sales were made.
Payment Schedules; Reports. The payments due pursuant to Sections 5.1 and 5.2 are due and payable on the dates described therein. Royalty payments due pursuant to Section 5.3 are due and payable within thirty (30) days of the end of each calendar quarter. IFF will accompany each payment of royalties under this Agreement with a report setting forth the amount of Reb C purchased from Suppliers for use in Products, and a calculation of the amount of royalty payment due on such purchases.